Fritah et al (31) found that inducing the expression of WISP-2 or supplementing the WISP-2 protein reduces the rate of proliferation, migration and invasion in WISP-2 (−) invasive human breast cancer cells. The gene discussed is CCN5; the disease is breast carcinoma.